146 related articles for article (PubMed ID: 22554937)
1. P-glycoprotein expression in canine mammary gland tumours related with myoepithelial cells.
Kim NH; Hwang YH; Im KS; Kim JH; Chon SK; Kim HY; Sur JH
Res Vet Sci; 2012 Dec; 93(3):1346-52. PubMed ID: 22554937
[TBL] [Abstract][Full Text] [Related]
2. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
[TBL] [Abstract][Full Text] [Related]
4. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
6. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
7. Expression of maspin in mammary gland tumors of the dog.
Espinosa de los Monteros A; Millán MY; Ramírez GA; Ordás J; Reymundo C; Martín de las Mulas J
Vet Pathol; 2005 May; 42(3):250-7. PubMed ID: 15872371
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.
Sánchez-Céspedes R; Millan Y; Guil-Luna S; García-Macías J; Maniscalco L; Iussich S; De Maria R; M de Las Mulas J
J Vet Diagn Invest; 2018 Jan; 30(1):155-160. PubMed ID: 29020879
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunohistochemical expression of P-glycoprotein in neoplasms of the mammary gland in bitches.
Badowska-Kozakiewicz AM; Malicka E
Pol J Vet Sci; 2010; 13(2):343-7. PubMed ID: 20731191
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
Kim JH; Yu CH; Yhee JY; Im KS; Sur JH
J Comp Pathol; 2010; 142(2-3):177-86. PubMed ID: 19959182
[TBL] [Abstract][Full Text] [Related]
13. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
14. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
15. Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.
Suárez-Bonnet A; Herráez P; Martín de las Mulas J; Rodríguez F; Déniz JM; Espinosa de los Monteros A
Vet J; 2011 Dec; 190(3):345-51. PubMed ID: 21251859
[TBL] [Abstract][Full Text] [Related]
16. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
18. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
19. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
20. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
